Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given an average rating of “Moderate Buy” by the seventeen analysts that are currently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $396.17.

ISRG has been the topic of a number of recent research reports. Barclays upped their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Mizuho increased their price objective on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Finally, Raymond James increased their price objective on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, President David J. Rosa sold 80,710 shares of the stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total value of $31,418,788.80. Following the transaction, the president now owns 163,399 shares in the company, valued at approximately $63,607,962.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 226,928 shares of company stock worth $87,833,828. Company insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the period. Able Wealth Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. Atticus Wealth Management LLC grew its holdings in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 41 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $371.70 on Friday. The firm’s 50-day moving average price is $385.79 and its 200-day moving average price is $348.35. The company has a market capitalization of $131.84 billion, a PE ratio of 67.09, a P/E/G ratio of 4.83 and a beta of 1.36. Intuitive Surgical has a 1-year low of $254.85 and a 1-year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.00 EPS. Equities analysts anticipate that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.